Comparative Study of Psychology and Glaucoma Knowledge in Glaucoma Day-ward Patients Inpatients

NCT ID: NCT03125850

Last Updated: 2020-07-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

240 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-08-10

Study Completion Date

2018-01-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will compare the glaucoma day-ward patients' efficacy with inpatients by evaluating the glaucoma knowledge and psychology , and will analysis the reasons of the differences. Half of participants will receive treatment in day-ward, while the other half will receive treatment in hospital.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Ophthalmic surgery has short operative time, quick recovery, and small anesthesia risk, making day case surgery the main management mode of ophthalmic surgery. This study will explore the differences of psychology and glaucoma knowledge between glaucoma day-ward patients and the inpatients. The data will be collected by scale on admission and discharge.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Glaucoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

day-ward group

Group Type EXPERIMENTAL

randomized to day ward

Intervention Type OTHER

Participants will be randomized to day-ward group, and will accept routine treatment, care, centralized education of glaucoma knowledge

inpatient group

Group Type ACTIVE_COMPARATOR

randomized to inpaitent

Intervention Type OTHER

Participants will be randomized to day-ward group, and will accept routine treatment, care, centralized education of glaucoma knowledge

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

randomized to day ward

Participants will be randomized to day-ward group, and will accept routine treatment, care, centralized education of glaucoma knowledge

Intervention Type OTHER

randomized to inpaitent

Participants will be randomized to day-ward group, and will accept routine treatment, care, centralized education of glaucoma knowledge

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patient is diagnosed with glaucoma;
2. Will receive glaucoma surgery;
3. Voluntary participation in this study;
4. Have enough language comprehension ability;
5. Best corrected visual acuity reach 0.1 or better;
6. Patient or his legal representative has sign the informed consent.

Exclusion Criteria

1. Patient with mental disorder;
2. There are important viscera function failure or other serious disease, including clinical related coronary artery disease, cardiovascular disease or myocardial infarction into the group of the first six months; serious neurological or psychiatric illness; serious infections; coagulant function abnormality; general active infectious diseases; malignant tumor; serious immune diseases;
3. Patient with monocular blindness;
4. Axial length≤20 mm;
5. With other serious eye diseases;
6. Neurologic diseases that could affect the visual field;
7. 3 months prior to research to participate in any clinical study;
8. Researchers think not suitable to participate in this clinical trial subjects;
9. Refused to sign the informed consent.
Minimum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Zhongshan Ophthalmic Center, Sun Yat-sen University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mingkai Lin

chief physician

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mingkai Lin, MD

Role: STUDY_CHAIR

Zhongshan Ophthalmic Center, Sun Yat-San University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Zhongshan Ophthalmic Center, Sun Yat-San Univerdity

Guangzhou, Guangdong, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Zhongshan OC

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.